Neurobo Pharmaceuticals Inc (NRBO)

NASDAQ
1.580
+0.130(+8.97%)
Pre Market
1.590
+0.010(+0.63%)
- Real-time Data
  • Volume:
    2,718,089
  • Day's Range:
    1.260 - 1.620
  • 52 wk Range:
    1.140 - 63.850

NRBO Overview

Prev. Close
1.45
Day's Range
1.26-1.62
Revenue
-
Open
1.36
52 wk Range
1.14-63.85
EPS
-15.63
Volume
2,718,089
Market Cap
10.28M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,886,643
P/E Ratio
-0.104
Beta
-0.958
1-Year Change
-96.83%
Shares Outstanding
6,503,528
Next Earnings Date
02 Apr 2023
What is your sentiment on Neurobo Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Neurobo Pharmaceuticals Inc News

Neurobo Pharmaceuticals Inc Company Profile

Neurobo Pharmaceuticals Inc Company Profile

Employees
5

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. It develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell